Merocyanine Crystallization Method

By dissolving the partial cyanine compound in polar organic solvents under pH less than 7 and performing crystallization treatment, the discoloration problem caused by impurities in commercial applications of partial cyanine compounds is solved, and high purity and improved color performance are achieved. , the resulting crystal has a low Gardner index and a high transmission value.

CN112424162BActive Publication Date: 2024-11-29BASF SE
View PDF 29 Cites 0 Cited by

Patent Information

Application Number
CN201980046319.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2019-07-09
Publication Date
2024-11-29
Estimated Expiration
2039-07-09

AI Technical Summary

Technical Problem

Existing cyanine compounds have undesirable discoloration problems caused by impurities in final commercial applications, especially in sunscreen formulations and packaging materials, resulting in poor color performance.

Method used

By dissolving the partial cyanine compound in a polar organic solvent and crystallizing and separation under pH less than 7, the addition of acids A1 and acid A2 is used to reduce impurity residues, and high purity and improved color performance are achieved.

Benefits of technology

The obtained cyanine crystal has a Gardner index less than 5 and a transmission value better than 90%, which significantly reduces impurity residues and improves color performance and purity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0002891200380000061
    Figure BDA0002891200380000061
  • Figure BDA0002891200380000071
    Figure BDA0002891200380000071
  • Figure BDA0002891200380000072
    Figure BDA0002891200380000072
Patent Text Reader

Abstract

The present invention relates to a process for preparing a crystalline merocyanine compound comprising the step of dissolving the merocyanine compound in a polar organic solvent, wherein the process is carried out in the presence of an acid at a pH of less than 7, wherein the residual level of colored impurities is eliminated.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention provides an improved crystallization process for merocyanine compounds with high purity and improved color properties. The process for preparing crystalline merocyanine comprises the steps of dissolving the merocyanine compound in a polar organic solvent, wherein the process is carried out at a pH of less than 7.

[0002] The 3-amino-2-cyclohexane-1-ylidene derivatives represented by the following formula (1) belong to the merocyanine chemical group and can be used as UV absorbers to protect household products from photolytic and oxidative degradation, as plastic additives, preferably in food and pharmaceutical packaging applications, for protecting food from photodegradation by incorporating these compounds into transparent food containers, for protecting UV-A sensitive drugs from photodegradation by incorporating UV absorbers into transparent blister foils or transparent pharmacy containers, as additives for photographic and printing applications, as additives for electronic applications and for protecting ingredients in agricultural applications.

[0003] The merocyanine derivatives of the present invention are produced via a multi-step sequence that is affected by the formation of colored by-products. Colored impurities have the disadvantage of causing undesirable discoloration in the final commercial application. Undesirable discoloration is usually observed as yellowing in the final commercial product such as sunscreen formulations or packaging materials. The ability of the merocyanine product containing the impurities to discolor the final product is related to its initial color before incorporation into the final product. The color of the merocyanine product can be determined by colorimetric measurements. Among these, determining the Gardner index is a common method with its determination of the yellowness of a substance. Samples of merocyanine products with higher levels of colored impurities show higher Gardner index values ​​and cause more significant discoloration in the final commercial product form. Therefore, it is desirable to reduce the residual level of colored impurities.

[0004] The object of the present invention is to provide 3-amino-2-cyclohexane-1-ylidene derivatives of the following formula (1) which no longer exhibit the above-mentioned disadvantages and which have improved color properties. It is therefore also an object of the present invention to provide an improved method for purifying and isolating such merocyanine compounds which minimizes discoloration in the final application system.

[0005] This object is achieved according to the invention by crystallizing the merocyanine compounds in specific solvents or solvent mixtures.

[0006] Surprisingly it has been found that these objects can be achieved by a process for preparing a crystalline merocyanine compound comprising the steps of:

[0007] (a) dissolving the merocyanine compound in a polar organic solvent,

[0008] (b) crystallizing the merocyanine compound from the solution obtained in step (a), and

[0009] (c) separating the merocyanine compound from the crystallization mixture of step (b),

[0010] The method is carried out at a pH of less than 7 according to the following scheme:

[0011] (i) adding acid A1 in step (a),

[0012] (ii) adding acid A2 in step (b), or

[0013] (iii) Acid A1 is added in step (a) and acid A2 is added in step (b).

[0014] The inventors surprisingly found that by the process for preparing crystalline merocyanine compounds as defined above, the merocyanine crystals thus obtained have a Gardner index of less than 5, measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630. Furthermore, the merocyanine crystals thus obtained surprisingly have excellent purity and improved transmission values ​​at 460 nm, preferably above 90%.

[0015] Thus, according to one embodiment, the present invention relates to an improved process for preparing a crystalline merocyanine compound of the formula:

[0016] (1)

[0017] in

[0018] R1 and R2 are independently hydrogen, C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally interrupted by one or more -O- and / or substituted by one or more OH;

[0019] R3 is (C=O)OR4 or (C=O)NHR4;

[0020] R4 is C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally substituted by one or more OH and / or interrupted by one or more -O-; and

[0021] R5 and R6 are independently hydrogen or C1-C 12 alkyl.

[0022] In another aspect, the present invention relates to crystals of merocyanine compounds obtainable by a process according to the process of the present invention for preparing crystalline merocyanine compounds as described herein.

[0023] In another aspect, the invention relates to a merocyanine compound having a Gardner index of less than 5 measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630.

[0024] In another aspect, the present invention relates to a method of reducing the residual level of colored impurities in a merocyanine compound by the method described herein.

[0025] In another aspect, the present invention relates to the use of crystals obtainable by a process according to the process of the present invention for preparing crystalline merocyanine compounds as described herein in a cosmetic formulation or packaging material.

[0026] The merocyanine compounds of formula (1) are illustratively prepared by reacting a solution of 1-aminocyclohexanone-3-ol having formula (2), wherein R1, R2, R5 and R6 are as defined in formula (1), with dimethyl sulfate or other suitable alkylating agents and subsequently with a suitable methylene-reactive compound of formula (3), wherein R3 is as defined in formula (1), as described, for example, in US-A-4,749,643, WO 2007 / 071582 A1, WO 2009027258 A2 or IP-COM000225139D.

[0027] (2)

[0028] (3)

[0029] The crude merocyanine product of formula (1) can be obtained from the reaction mixture by standard product isolation procedures, such as liquid-liquid separation, filtration, column chromatography, crystallization by cooling, by adding a poor solvent to the reaction mixture, by distillation, or a combination of these isolation methods.

[0030] Before describing exemplary embodiments of the present invention in detail, definitions important for understanding the present invention are given.

[0031] As used in this specification and the appended claims, the singular forms "a" and "an" also include the corresponding plural forms, unless the context clearly provides otherwise. In the context of the present invention, the term "about" means that a person skilled in the art will understand that the accuracy interval of the technical effect of the feature is still ensured. The term usually means a deviation from the numerical value shown by ± 20%, preferably ± 15%, more preferably ± 10%, and even more preferably ± 5%. It should be understood that the term "comprising" is not restrictive. For the present invention, the term "consisting of..." is considered to be a preferred embodiment of the term "comprising". If a group is defined below as including at least a certain number of embodiments, this means that a group preferably consisting of only these embodiments is also included. In addition, the terms "first", "second", "third" or "(a)", "(b)", "(c)", "(d)" and the like in the specification and claims are used to distinguish similar elements and are not necessarily used to describe sequential or chronological order. It should be understood that the terms used in this way are interchangeable under appropriate circumstances and that the embodiments of the present invention described herein can be operated in other sequences other than those described or shown herein. Where the terms "first", "second", "third" or "(a)", "(b)", "(c)", "(d)", "(i)", "(ii)" etc. refer to steps of a method or use or analysis, there is no temporal or temporal time coherence between the steps, i.e., the steps may be performed simultaneously or there may be time intervals of seconds, minutes, hours, days, weeks, months or even years between the steps, unless otherwise indicated in the present application as described in the context. It should be understood that the present invention is not limited to the specific methods, procedures, reagents, etc. described herein, as they may vary. It should be understood that the terminology used herein is intended to describe specific embodiments only and is not intended to limit the scope of the invention, which is limited only by the appended claims. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.

[0032] The terms "crude merocyanine product" and "crude merocyanine material" relate to the merocyanine compound added in step (a) of the process to prepare the crystalline merocyanine compound, and thus to the merocyanine compound obtained, for example, via a multi-step sequence before carrying out the crystallization process of the invention. Prior to carrying out the crystallization process of the invention, the crude merocyanine product may be purified by any other possible purification method after the multi-step sequential synthesis. However, the crystallization process of the invention may also be carried out directly after the crude merocyanine product has been obtained by the multi-step sequential synthesis, without any prior purification method.

[0033] The term "crystallization mixture" relates to the total weight % (wt%) of the mixture comprising all components in that particular step within the process.

[0034] The organic moieties mentioned in the above definitions of the variables are collective terms for individual enumerations of the individual group members. n -C m In each case it indicates the possible number of carbon atoms in the group.

[0035] With regard to the variables, particularly preferred embodiments of the merocyanine compounds correspond to those of the compounds of the formula (1).

[0036] The variables of the compounds of formula (1) have the following meanings, wherein these meanings alone and in combination with one another are preferred embodiments of the compounds of the following formula:

[0037] (1)

[0038] in

[0039] R1 and R2 are independently hydrogen, C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally interrupted by one or more -O- and / or substituted by one or more OH;

[0040] R3 is (C=O)OR4 or (C=O)NHR4;

[0041] R4 is C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally substituted by one or more OH and / or interrupted by one or more -O-; and

[0042] R5 and R6 are independently hydrogen or C1-C 12 alkyl.

[0043] The term "C1-C 22 “Alkyl” in each case denotes a straight-chain or branched alkyl radical, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, 2-pentyl, 3-pentyl, 2,2-dimethylpropyl, n-hexyl, n-octyl, 1,1,3,3-tetramethylbutyl, 2-ethylhexyl, nonyl, decyl, n-octadecyl, eicosyl or dodecyl.

[0044] The term "C2-C 22"Alkenyl" in each case means a straight-chain or branched alkenyl radical having at least one monounsaturated hydrocarbon radical, i.e. a hydrocarbon radical having at least one carbon-carbon double bond, such as a straight-chain C2-C 12 Alkenyl or preferably branched C3-C 12 Other examples are C1-C 12 Alkyl groups such as vinyl, allyl, 2-propen-2-yl, 2-buten-1-yl, 3-buten-1-yl, 1,3-butadien-2-yl, 2-cyclobuten-1-yl, 2-penten-1-yl, 3-penten-2-yl, 2-methyl-1-buten-3-yl, 2-methyl-3-buten-2-yl, 3-methyl-2-buten-1-yl, 1,4-pentadien-3-yl, 2-cyclopenten- The invention can be any of the following: cyclohexen-1-yl, 2-cyclohexen-1-yl, 3-cyclohexen-1-yl, 2,4-cyclohexadien-1-yl, 1-p-menthene-8-yl, 4(10)-thuja-10-yl, 2-norbornene-1-yl, 2,5-norbornadien-1-yl, 7,7-dimethyl-2,4-norcaradien-3-yl, or different isomers of hexenyl, octenyl, nonenyl, decenyl or dodecenyl.

[0045] The term "C2-C 22 “Alkynyl” in each case denotes a hydrocarbon radical having at least one carbon-carbon triple bond, where the chain may be straight-chain or branched, such as ethynyl, propargyl (2-propyn-1-yl, also called prop-2-yn-1-yl), 1-propyn-1-yl (also called prop-1-yn-1-yl), 1-methylprop-2-yn-1-yl, 2-butyn-1-yl, 3-butyn-1-yl, 1-pentyn-1-yl, 3-pentyn-1-yl, 4-pentyn-1-yl, 1-methylbut-2-yn-1-yl, 1-ethylprop-2-yn-1-yl and the like.

[0046] The term "C3-C 22 "Cycloalkyl" in each case denotes a mono- or polycyclic alicyclic radical, such as cyclopropyl, cyclobutyl, cyclopentyl, trimethylcyclohexyl or preferably cyclohexyl.

[0047] The term "C3-C 22 "Cycloalkenyl" in each case denotes a monocyclic or polycyclic monounsaturated nonaromatic radical. A cycloalkenyl radical can be bonded to the remainder of the molecule via a carbon atom which forms a double bond or via a carbon atom which forms a single bond, preferably via a carbon atom which forms a double bond. Exemplary cycloalkenyl radicals include cyclopropen-1-yl, cyclohexen-1-yl, cyclohepten-1-yl or cycloocten-1-yl.

[0048] The term "interrupted by one or more -O- groups" preferably refers to any ether group like methoxyethyl, ethoxypropyl, 2-ethoxyethyl, 3-methoxypropyl, 2-butoxyethyl or 2-(2-methoxyethoxy)ethyl.

[0049] The term "substituted by one or more OH groups" preferably refers to "hydroxy-substituted alkyl groups" such as hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl, hydroxypentyl, hydroxyhexyl, hydroxyheptyl, hydroxyoctyl, hydroxynonyl or hydroxydecyl.

[0050] The term "aliphatic" may relate to any non-aromatic hydrocarbon radical, wherein the constituent carbon atoms may be linear, branched or cyclic and / or wherein heteroatoms may be bonded to the carbon chain. In addition, these aliphatic groups may be substituted by one or more identical or different substituents.

[0051] Within the meaning of the present invention, the term "high purity" refers to compounds having a purity of at least 90% by weight, preferably at least 95% by weight, more preferably at least 97% by weight, based on the total weight of the final purified product, wherein the remaining weight % corresponds to impurities.

[0052] The merocyanine compounds of the present invention may be in the form of E,E-, E,Z- or Z,Z-geometric isomers.

[0053] In one embodiment, the present invention is directed to a process for preparing crystalline merocyanine compounds of formula (1) shown below and abbreviated as MC01-MC10, M15 and M27.

[0054] Examples of merocyanines of the present invention are listed in Table A:

[0055]

[0056]

[0057] The most preferred merocyanine derivatives of the present invention are selected from the following compounds and their E,E-, E,Z- or Z,Z- geometric isomer forms:

[0058]

[0059] According to a particular embodiment of the invention, the merocyanine compound is 2-ethoxyethyl (2Z)-cyano-{3-[(3-methoxypropyl)amino]cyclohex-2-en-1-ylidene}acetate.

[0060] According to one embodiment of the present invention, the merocyanine compound is provided in step (a) at a concentration ranging from about 50-600 g / L, preferably about 100-580 g / L, more preferably about 200-550 g / L.

[0061] The weight ratio of the polar organic solvent to the acid A1 and / or A2 is about 500:1-0.5:1, preferably about 400:1-0.8:1, and more preferably about 350:1-1:1.

[0062] According to the present invention, the method for preparing a crystalline merocyanine compound comprises the following steps:

[0063] (a) dissolving the merocyanine compound in a polar organic solvent,

[0064] (b) crystallizing the merocyanine compound from the solution obtained in step (a), and

[0065] (c) separating the merocyanine compound from the crystallization mixture of step (b),

[0066] The method is carried out at a pH of less than 7.

[0067] In step (a), the merocyanine compound (ie the crude merocyanine product) is dissolved in a polar organic solvent. According to one embodiment of the present invention, the organic solvent is selected from esters, ketones, ethers, alcohols and mixtures thereof.

[0068] Suitable ester solvents can be methyl formate, ethyl formate, butyl formate, isobutyl formate, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, isobutyl acetate, sec-butyl acetate, amyl acetate, isoamyl acetate, 2-ethylhexyl acetate, octyl acetate, nonyl acetate, hexyl acetate, ethoxypropyl acetate, propionate, ethyl 3-ethoxypropionate, butyrate, butyl butyrate, ethyl lactate, butyl lactate, butyl glycolate and dimethyl adipate or mixtures thereof. Preferably, an ester solvent selected from formate, acetate or propionate solvents is used.

[0069] Also suitable are ketones such as acetone, methyl ethyl ketone, methyl propyl ketone, methyl butyl ketone, methyl isobutyl ketone, methyl amyl ketone, ethyl amyl ketone, dipropyl ketone, diisopropyl ketone, diisobutyl ketone, mesityl oxide, cyclohexanone, methylcyclohexanone, isophorone or mixtures thereof.

[0070] Ether solvents such as diethyl ether, diisopropyl ether, dibutyl ether, di-sec-butyl ether, methyl tert-butyl ether, tetrahydrofuran, 1,4-dihydrofuran Alkane, 1,3-di Alkanes and glycol ethers such as methyl glycol, 2-ethoxyethanol, 2-propoxyethanol, 2-butoxyethanol, methyl diglycol, butyl diglycol, ethyl glycol, ethyl triglycol, butyl tetraglycol, diethylene glycol dimethyl ether, butyl triglycol, methoxypropanol, isobutoxypropanol, methyl dipropylene glycol, methoxybutanol and 1,1-dimethoxyethane are suitable.

[0071] Suitable alcohol solvent can be methanol, ethanol, propyl alcohol, isopropyl alcohol, butanol, isobutyl alcohol, sec-butyl alcohol, the tert-butyl alcohol, amyl alcohol, amyl alcohol, isoamyl alcohol, hexanol, 2-ethylhexanol, benzyl alcohol, cyclohexanol, methylcyclohexanol, furfuryl alcohol, tetrahydrofurfuryl alcohol, diacetone alcohol or its mixture. Preferably use isopropyl alcohol, sec-butyl alcohol, the tert-butyl alcohol, tert-amyl alcohol, tert-octanol or its mixture.

[0072] In a preferred embodiment, the polar organic solvent is selected from diisopropyl ether, methyl isobutyl ketone, butyl acetate, isobutyl acetate, n-propyl acetate, isoamyl acetate, ethyl 3-ethoxypropionate, ethyl propionate, 1-methoxy-2-propanol and mixtures thereof.

[0073] The temperature of the solution obtained in step (a) may be in the range of about 0°C to the boiling point of the solvent or solvent mixture used in this step, preferably about 20-100°C, most preferably 30-80°C.

[0074] In one embodiment, the crude merocyanine product can be first melted and then dissolved in the polar organic solvent. In this regard, the melt generally needs to be first cooled before adding the polar organic solvent.

[0075] In some cases it may be advantageous to add the acid A1 in step (a) of the process. The acid A1 may here be added to the polar organic solvent before or after dissolving the merocyanine compound.

[0076] In other cases, it may be advantageous to add the acid A2 at any other stage of the crystallization step, such as in step (b). The acid A2 may be added to the crystallization mixture, for example, after cooling the crystallization mixture obtained in step (a), after seeding the coarse merocyanine solution or during crystallization.

[0077] In other cases, it may be advantageous to add acid A1 in step (a) of the process and acid A2 in step (b) of the process. Thus, acid A1 may be added to the polar organic solvent before or after dissolving the merocyanine compound and acid A2 may be added to the crystallization mixture after cooling the crystallization mixture obtained in step (a), after seeding the crude merocyanine solution or during crystallization.

[0078] Crystallization of the merocyanine compound from the solution obtained in step (a) can be achieved by all possible common crystallization methods, such as adding a solvent in which the merocyanine compound is not very soluble to the crystallization mixture, cooling the crystallization mixture, evaporating the solvent from the crystallization mixture, adding seed crystals of the merocyanine compound to the crystallization mixture or a combination thereof.

[0079] In one embodiment of the present invention, the crystallization of the merocyanine compound from the crystallization mixture is carried out as follows:

[0080] - cooling the crystallization mixture,

[0081] - adding seed crystals of the merocyanine compound to the crystallization mixture, and / or

[0082] - Add acid A2.

[0083] The temperature used in step (b) may range from about -10°C to below the boiling point of the crystallization mixture, preferably from about -5°C to 100°C, more preferably from -5°C to 70°C.

[0084] The seeding can be carried out by adding seeds, which can be added in any known manner. The seeds can be added illustratively while stirring the crystallization mixture. The amount of seeds added to the crystallization mixture is generally in the range of about 0.01-2 wt %, preferably about 0.05-1.8 wt %, based on the total weight of the crystallization mixture.

[0085] According to the present invention, acid A1 and / or acid A2 can be added by the following scheme:

[0086] (i) adding acid A1 in step (a),

[0087] (ii) adding acid A2 in step (b), or

[0088] (iii) adding acid A1 in step (a) and acid A2 in step (b),

[0089] This results in the pH of the crystallization mixture being below 7.

[0090] According to the present invention, any suitable acid can be used as acid A1 and acid A2. According to the present invention, acid A1 and acid A2 are independently selected from organic acids, inorganic acids and mixtures thereof, wherein any suitable amount can be used. Preferably, acid A1 and acid A2 are independently selected from acetic acid, aspartic acid, benzoic acid, boric acid, bromic acid, hydrochloric acid, citric acid, formic acid, gluconic acid, glutamic acid, hydrochloric acid, lactic acid, malic acid, nitric acid, sulfamic acid, sulfuric acid, methanesulfonic acid, toluenesulfonic acid, tartaric acid, phosphoric acid, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid and mixtures thereof. Preferably, hydrochloric acid, formic acid or acetic acid are used. Even more preferably, sulfonic acids such as methanesulfonic acid are used.

[0091] In a particular embodiment, acid A1 is formic acid and acid A2 is methanesulfonic acid.

[0092] In one embodiment of the present invention, the process is carried out according to scheme (i). Thus, acid A1 is added in step (a). In certain embodiments, the process is carried out according to scheme (i) and the polar organic solvent is preferably an ester.

[0093] In another embodiment of the invention, the process is carried out according to variant (ii) or (iii). Thus, acid A2 is added in step (b) or acid A1 is added in step (a) and acid A2 is added in step (b).

[0094] The total amount of acids A1 and / or A2 is in the range of 0.001 to 50% by weight, preferably 0.01 to 20% by weight, even more preferably 0.10 to 10% by weight, based on the total weight of the crystallization mixture.

[0095] Step (b) may be carried out while stirring. Stirring may be carried out during the crystallization process, as long as the stirring is carried out in a manner that does not interfere with the crystallization process.

[0096] When crystallization is performed, the stirring time may vary. The stirring time may be in the range of 2-30 hours, preferably 4-20 hours, even more preferably 5-15 hours.

[0097] In a specific embodiment, the present invention relates to a method wherein the step (a) of dissolving the merocyanine compound in a polar organic solvent is performed by heating the mixture to boiling point, and wherein the step (b) of crystallizing the merocyanine compound from the solution obtained in step (a) is performed by cooling the crystallization mixture to a temperature in the range of -10°C to below the boiling point of the crystallization mixture.

[0098] In another specific embodiment, the present invention relates to a process wherein the step (a) of dissolving the merocyanine compound in a polar organic solvent is carried out by heating the mixture to boiling point, and wherein the step (b) of crystallizing the merocyanine compound from the solution obtained in step (a) is carried out by seeding the crystallization mixture comprising the crude merocyanine solution.

[0099] In another specific embodiment, the present invention relates to a process wherein step (a) of dissolving the merocyanine compound in a polar organic solvent is performed by heating the mixture to boiling point, and wherein step (b) of crystallizing the merocyanine compound from the solution obtained in step (a) is performed by cooling the crystallization mixture to a temperature in the range of -10°C to below the boiling point of the crystallization mixture and additionally seeding the crystallization mixture comprising the crude merocyanine solution.

[0100] In step (c) the crystalline merocyanine compound may be separated from the mixture by any conventional method such as filtration, centrifugation or evaporation of the solvent. Separation by filtration or centrifugation is preferred.

[0101] The present invention provides for a reduction in the residual level of colored impurities in merocyanine compounds by the methods described herein.

[0102] The resulting crystals of the merocyanine compound are usually dried in an optional step (d) after the separation in step (c). Drying can be carried out by any known method such as washing with a solvent, drying at room temperature or any higher temperature, freeze drying, under vacuum, etc. The material obtained under (c) is preferably dried at a temperature above 50°C and under vacuum.

[0103] In a particular embodiment, the invention relates to a method as described above, wherein the crystalline merocyanine compound has a Gardner index measured on a spectrophotometer PE (PerkinElmer) Lambda 650 according to DIN EN ISO 4630 of less than 5, preferably less than 3.2.

[0104] The present invention further relates to crystals of merocyanine compounds obtainable by the process of the present invention.

[0105] In one embodiment, the crystals of the merocyanine compound obtainable by the process according to the invention have a Gardner index measured on a spectrophotometer PE (PerkinElmer) Lambda 650 according to DIN EN ISO 4630 of less than 5, preferably less than 3.2. In another embodiment, the crystals of the merocyanine compound obtainable by the process according to the invention have a transmission value at 460 nm of greater than 90%. In a specific embodiment of the present invention, the crystals of the merocyanine compound obtainable by the process according to the invention have a Gardner index measured on a spectrophotometer PE (PerkinElmer) Lambda 650 according to DIN EN ISO 4630 of less than 5, preferably less than 3.2 and a transmission value at 460 nm of greater than 90%.

[0106] The obtained crystals of the merocyanine compound further preferably have higher purity.

[0107] The crystals of the merocyanine compound obtained by the process of the present invention show low discoloration properties. In order to compare the crystals of the merocyanine compound with the coarse merocyanine product, the Gardner Index and the % transmission at a wavelength of 460 nm can be determined. The crystals of the merocyanine compound obtained by the process of the present invention show a significantly lower Gardner Index, typically below 3.2 and ideally below 3.0 for many applications. In contrast, coarse merocyanine materials have a Gardner Index of over 5 and higher.

[0108] The measured % transmission values ​​of the crystals of the merocyanine compound obtained by the process of the present invention measured at a wavelength of 460 nm are significantly higher than those of the rough merocyanine material, indicating lower absorption properties in the visible region. The crystals of the merocyanine compound of the present invention show % transmission values ​​of 90% and higher at 460 nm, while the rough merocyanine material generally has values ​​of 10% and below.

[0109] In one embodiment, the present invention relates to a crystalline merocyanine compound of the formula:

[0110] (1)

[0111] in

[0112] R1 and R2 are independently hydrogen, C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally interrupted by one or more -O- and / or substituted by one or more OH;

[0113] R3 is (C=O)OR4 or (C=O)NHR4;

[0114] R4 is C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally substituted by one or more OH and / or interrupted by one or more -O-; and

[0115] R5 and R6 are independently hydrogen or C1-C 12 alkyl,

[0116] Wherein the crystalline merocyanine compound has a Gardner index, measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630, of less than 5, preferably of less than 3.2.

[0117] In another embodiment, the present invention is directed to a crystalline merocyanine compound of the formula:

[0118] (1)

[0119] in

[0120] R1 and R2 are independently hydrogen, C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally interrupted by one or more -O- and / or substituted by one or more OH;

[0121] R3 is (C=O)OR4 or (C=O)NHR4;

[0122] R4 is C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C22 Cycloalkenyl, wherein the above moiety is optionally substituted by one or more OH and / or interrupted by one or more -O-; and

[0123] R5 and R6 are independently hydrogen or C1-C 12 alkyl,

[0124] The crystalline merocyanine compound has a transmittance value of greater than 90% at 460 nm.

[0125] In yet another embodiment, the present invention relates to a crystalline merocyanine compound of the formula:

[0126] (1)

[0127] in

[0128] R1 and R2 are independently hydrogen, C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally interrupted by one or more -O- and / or substituted by one or more OH;

[0129] R3 is (C=O)OR4 or (C=O)NHR4;

[0130] R4 is C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally substituted by one or more OH and / or interrupted by one or more -O-; and

[0131] R5 and R6 are independently hydrogen or C1-C 12 alkyl,

[0132] wherein the crystalline merocyanine compound has a Gardner index measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630 of less than 5, preferably less than 3.2 and wherein the crystalline merocyanine compound has a transmission value at 460 nm of higher than 90%.

[0133] The crystalline merocyanine compound of formula (1) further preferably has a higher purity.

[0134] The present invention further relates to the use of crystals of merocyanine compounds obtainable by the process of the present invention and to the use of crystalline merocyanine compounds of formula (1) of the present invention. The present invention particularly relates to the use of merocyanine compounds obtainable by the process of the present invention in cosmetic formulations or packaging materials. The present invention further relates to the use of crystalline merocyanine compounds of formula (1) of the present invention in cosmetic formulations or packaging materials. Preferably, such compounds are used as UV absorbers.

[0135] The crystals of the merocyanine compound obtainable by the process of the present invention and the crystalline merocyanine compound of formula (1) of the present invention may be mixed with any other UV absorber.

[0136] In one embodiment, the crystals according to the invention are used as individual component or in a mixture with other UV absorbers in cosmetic formulations such as skin care products, bath additives, preparations containing fragrances and aroma substances, hair care products, dentifrices, deodorant and antiperspirant preparations, decorative preparations and photoprotective formulations.

[0137] The photoprotective formulations according to the invention are exemplarily sunscreen milks, sunscreen lotions, sunscreen creams or sunscreen oils, sunscreen preparations or tropical pre-tanning preparations or after-sun preparations.Crystals are useful in photoprotective formulations.

[0138] In one embodiment, the crystals of the invention are used as a sole component or in a mixture with other UV absorbers in packaging materials, preferably in transparent packaging materials, such as for protecting food or pharmaceutical packaging applications.

[0139] In a further embodiment, the crystals according to the invention are used as individual component or in a mixture with other UV absorbers in photographic recording materials.

[0140] Due to the improved UV-A and UV-B absorption properties of the crystals according to the invention, products packaged with the packaging material according to the invention are excellently protected against UV-A and UV-B radiation.

[0141] Analytical methods:

[0142] Gardner Index

[0143] The Gardner Index can usually be measured on a typical device. In the present invention, the Gardner Index is measured on a spectrophotometer PE (PerkinElmer) Lambda 650 in accordance with DIN EN ISO 4630.

[0144] HPLC standard method

[0145] Liquid chromatography with DAD detection was performed.

[0146] As a column, Zorbax Eclipse XDB-C18 1.8μ, 4.6×100 mm (Agilent) was used.

[0147] Mobile phase A: water and 0.05% formic acid.

[0148] Mobile phase B: acetonitrile and 0.05% formic acid.

[0149] The standard HPLC gradient used is given in Table B.

[0150]

[0151] The flow rate was 0.7 mL / min, the injection volume was 3 μL and the temperature was 47° C. Detection was performed at a wavelength of 230 nm.

[0152] % Transmission 460nm

[0153] As spectrophotometer a Lamda 35 was used and as thermostat a Polystat CC3-Huber G3 was used.

[0154] Select the following parameters:

[0155] Wavelength: 460nm

[0156] Tank Type: Quartz, 10mm

[0157] Measuring Mode: Transmission

[0158] Number of cycles: 1

[0159] Response: 2

[0160] Lights: 2

[0161] Slit: 2.00nm

[0162] Temperature: 25℃

[0163] Test solution: 1.00% w / v in ethanol

[0164] Reference: (Baseline / reference beam): Use corresponding blank solution

[0165] Solvents: Anhydrous denatured ethanol, spectrophotometric grade; 90%. 5% methanol, 5% isopropanol - Alfa Aesar Art.Nr.22931

[0166] About 50.0 mg of the corresponding sample is weighed into a 5.00 mL volumetric flask and filled to the mark with ethanol to give a 1% w / v solution in ethanol. If necessary, the sample is treated in an ultrasonic bath for 1-2 minutes.

[0167] purity

[0168] Purity was determined via the HPLC standard method as described above.

[0169] The present invention is further illustrated by the following examples. Example

[0170] Crystallization of merocyanine UV absorber

[0171] Comparative Example: Crystallization of MC03 compound in the absence of acid

[0172] At 64°C, 30.0g of compound MC03 (a crude product with a Gardner index of 10.7 and a purity of 95.4%) was dissolved in 70.0g of n-butyl acetate. Cooled to 53°C under stirring, 0.16g of crystalline compound MC03 was then added as a seed. The temperature was then lowered to 10°C in 15.3 hours. A temperature of 10°C was maintained for 0.5 hours. The suspension was then transferred to a Buchner funnel and the mother liquor was filtered off by suction. The filter cake was rinsed with 30.0g of butyl acetate. 30.0g of butyl acetate was then added, and the filter cake was re-slurried in the washing solution using a spatula and the washing solution was filtered off by suction. The crystals were finally rinsed with 30.0g of butyl acetate. The crystals were then dried in a vacuum oven at 85°C and 20 mbar for 16 hours to obtain 25.1g (87.1% yield) of pure product of formula MC03. Gardner Index: 7.7, %T 460nm: 2.4, Purity: 98.8%.

[0173] Example 1: Crystallization of Compound MC03 Using Formic Acid and Methanesulfonic Acid in Ether Solvent

[0174] 50.0 g of compound MC03 (a crude product with a Gardner index of 10.7 and a purity of 95.8%) was transferred to a dropping funnel with a heating jacket. The jacket was heated to 120° C. until the crude product was completely melted. The funnel with the crude product melt was placed on a reaction vessel equipped with an anchor impeller, a thermometer, a cooling jacket and an outlet spindle on the bottom of the vessel.

[0175] Under stirring, 111.8g of diisopropyl ether and 35.5g of formic acid were added to the reactor and heated to 32°C. The crude product melt was added while maintaining the mixture temperature at 32°C and maintaining a stirring speed at 350 rpm in 15 minutes. Then 0.64g of methanesulfonic acid and 1.11g of crystalline compound MC03 were added to the mixture. In 1 hour, the stirrer speed was reduced to 200rpm and the heating temperature was reduced from 32°C to 29°C. Then the cooling temperature was linearly reduced to 19°C in 240 minutes, and then the cooling temperature was reduced to -8°C in 648 minutes, resulting in an internal temperature of -5°C. The internal temperature of -5°C was maintained for 0.5 hour. Then the suspension was transferred to a Buchner funnel and the mother liquor was filtered off by suction. The filter cake was rinsed with 44.4g of diisopropyl ether / formic acid (95:5). The filter cake was then washed with 133.2 g of diisopropyl ether in 4 portions, from which the second portion was used to reslurry the filter cake in the washing liquid before filtering off the washing liquid with suction. The washed product crystals were dried in a vacuum oven at 65° C. and 20 mbar for 16 hours to give 39.6 g (80.4% yield) of crystalline product. Gardner Index = 3.0, %T 460nm: 93.3.

[0176] Example 2: Crystallization of Compound MC03 Using Formic Acid and Methanesulfonic Acid in Ether Solvent

[0177] At 50°C, 26.1g of compound MC03 (a crude product with a Gardner index of 8.6 and a purity of 95.9%) was dissolved in 17.7g of formic acid and 55.8g of diisopropyl ether, and then 0.32g of methanesulfonic acid was added. Cooled to 32°C under stirring, 1.25g of compound MC03 was then added as a seed. The cooling temperature was then reduced to -8°C in 912 minutes. The cooling temperature of -8°C was maintained for 0.5 hours. The suspension was then transferred to a Buchner funnel and the mother liquor was filtered off by suction. The filter cake was rinsed with 50.0g of diisopropyl ether / formic acid (95:5). The filter cake was then washed in 4 batches with 150.0g of diisopropyl ether. The washed product crystals were dried in a vacuum oven at 65°C and 20 mbar for 16 hours to obtain 21.5g (80.9% yield) of crystalline product. Gardner Index: 2.7, %T460nm: 96.1.

[0178] Example 3: Crystallization of Compound MC03 Using Methanesulfonic Acid in an Ester Solvent

[0179] At 54°C, 25.0 g of compound MC03 (a crude product with a Gardner index of 10.6 and a purity of 95.3%) was dissolved in 75.0 g of butyl acetate. Cooled to a temperature of 46°C, 0.30 g of methanesulfonic acid and 0.13 g of crystalline MC03 were then added to put in seed crystals. The cooling temperature was then reduced to -8°C, resulting in a temperature of -5°C in the mixture. The cooling temperature of -8°C was maintained for 0.5 hours. The crystals were then separated by filtration and washed in 3 batches with 110.0 g of butyl acetate. The product crystals were then dried at 65°C and 20 mbar for 16 hours to obtain 20.0 g (83.3% yield) of a crystalline product of formula MC03. Gardner index: 2.7, %T460nm: 98.2.

[0180] Example 4: Crystallization of Compound MC03 Using Formic Acid in an Ester Solvent

[0181] At 49°C, 20.0g of compound MC03 (a crude product with a Gardner index of 10.6 and a purity of 95.3%) was dissolved in 70.0g of butyl acetate and 10.0g of formic acid. Cooled to a temperature of 26°C, 0.10g of crystalline MC03 was then added to put in a seed crystal. The cooling temperature was then reduced to 7°C, resulting in a temperature of 10°C in the mixture. The cooling temperature of 7°C was maintained for 0.5 hours. The crystals were then separated by filtration and rinsed with 40.0g of diisopropyl ether. 50.0g of diisopropyl ether was then added, and the filter cake was re-slurried in the washing liquid using a spatula and the washing liquid was filtered out by suction. Finally, the crystals were rinsed with 50.0g of diisopropyl ether. The crystals were then dried in a vacuum oven at 65°C and 20 mbar for 64 hours to obtain 9.14g (47.4% yield) of pure product. Gardner index: 2.8, %T 460nm: 97.9.

[0182] Example 5: Crystallization of Compound MC03 Using Methanesulfonic Acid in an Ester Solvent

[0183] At 55°C, 20.0g of compound MC03 (a crude product with a Gardner index of 10.6 and a purity of 95.3%) was dissolved in 80.0g of n-propyl acetate. After cooling to a temperature of 41°C, 0.24g of methanesulfonic acid and 0.10g of crystals of formula MC03 were added to put in seeds. The cooling temperature was then reduced to -8°C, resulting in a temperature of -5°C in the mixture. The cooling temperature of -8°C was maintained for 0.5 hours. The crystals were then separated by filtration and rinsed with 30.0g of cooled n-propyl acetate (the temperature of the washing liquid was 5°C). 40.0g of cooled n-propyl acetate was then added, and the filter cake was re-slurried in the washing liquid using a spatula and the washing liquid was filtered out by suction. Finally, the crystals were rinsed with 40.0g of cooled propyl acetate. The crystals were then dried in a vacuum oven at 65°C and 20 mbar for 64 hours to obtain 14.81g (77.2% yield) of pure product. Gardner Index: 2.8, %T 460nm: 97.4.

[0184] Example 6: Crystallization of Compound MC03 Using Methanesulfonic Acid in Ketone Solvent

[0185] At 49°C, 30.0g of compound MC03 (a crude product with a Gardner index of 10.7 and a purity of 95.4%) was dissolved in 70.0g of methyl isobutyl ketone. The mixture was cooled to a temperature of 43°C, and then 0.36g of methanesulfonic acid and 0.16g of MC03 crystals were added to put in seed crystals. The cooling temperature was then reduced to 7°C, resulting in a temperature of 11°C in the mixture. The cooling temperature of 7°C was maintained for 0.5 hours. The crystals were then separated by filtering with a Buchner funnel equipped with filter paper and rinsed with 30.0g of cooled methyl isobutyl ketone (the temperature of the washing liquid was 14°C). 30.0g of cooled methyl isobutyl ketone was then added, and the filter cake was re-slurried in the washing liquid using a spatula and the washing liquid was filtered out by suction. Finally, the crystals were rinsed with 30.0g of cooled methyl isobutyl ketone. The crystals were then dried in a vacuum oven at 70°C and 20 mbar for 2 hours and then at 80°C and 20 mbar for 16 hours to give 17.8 g (61.6% yield) of pure product. Gardner Index: 2.9, %T 460nm: 96.9.

[0186] Example 7: Crystallization of Compound MC03 Using Methanesulfonic Acid in an Ester Solvent

[0187] At 68°C, 30.0 g of compound MC03 (a crude product with a Gardner index of 10.7 and a purity of 95.4%) was dissolved in 70.0 g of isoamyl acetate. The mixture was cooled to a temperature of 58°C, and then 0.36 g of methanesulfonic acid and 0.16 g of MC03 crystals were added to put in seed crystals. The cooling temperature was then reduced to 7°C over 17 hours, resulting in a temperature of 10°C in the mixture. The cooling temperature of 7°C was maintained for 0.5 hours. The crystals were then separated by filtration using a Buchner funnel equipped with filter paper and rinsed with 30.0 g of cooled isoamyl acetate (the temperature of the washing liquid was 14°C). 30.0 g of cooled isoamyl acetate was then added, and the filter cake was re-slurried in the washing liquid using a spatula and the washing liquid was filtered out by suction. The crystals were finally rinsed with 30.0 g of cooled isoamyl acetate. The crystals were then dried in a vacuum oven at 70°C and 20 mbar for 2 hours and then at 85°C and 20 mbar for 16 hours to give 26.0 g (90.2% yield) of pure product. Gardner Index: 2.9, %T 460nm: 96.3.

[0188] Example 8: Crystallization of Compound MC03 Using Methanesulfonic Acid in an Ester Solvent

[0189] At 64 ℃, 36.0g of compound MC03 (Gardner index is 10.7 and purity is 95.4% crude product) is dissolved in 60.0g 3-ethoxy ethyl propionate. Cool to a temperature of 52 ℃, then add a solution of 0.41g of methanesulfonic acid in 3.00g 3-ethoxy ethyl propionate through a funnel, and then rinse the funnel with 1.00g 3-ethoxy ethyl propionate. Cool to 50 ℃ and add 0.18g of MC03 crystal to put in seed crystal. Then in 17 hours, the cooling temperature is reduced to -1 ℃, resulting in a temperature of 5 ℃ in the mixture. The cooling temperature of -1 ℃ is maintained for 1 hour. Then separate the crystals by filtering with a Buchner funnel equipped with filter paper and filter out the mother liquor by suction. Then rinse the filter cake with 40.0g of mother liquor (the temperature of the washing liquid is 9 ℃). 30.0 g of cooled ethyl 3-ethoxypropionate were then added (temperature of the washing liquid: 9° C.), the filter cake was reslurried in the washing liquid using a spatula and the washing liquid was filtered off with suction. The crystals were finally rinsed with 30.0 g of cooled ethyl 3-ethoxypropionate. The crystals were then dried in a vacuum oven at 85° C. and 20 mbar for 64 hours to give 29.9 g (86.6% yield) of crude product. Gardner index: 2.9, %T460nm: 95.3. Purity: 98.1%.

[0190] Example 9: Crystallization of Compound MC03 Using Methanesulfonic Acid in an Ester Solvent

[0191] At 75°C, 38.0 g of compound MC03 (a crude product with a Gardner index of 10.7 and a purity of 95.4%) was dissolved in 62.0 g of isobutyl acetate. After cooling to a temperature of 54°C, 0.385 g of methanesulfonic acid and 0.18 g of MC03 crystals were added to put in seed crystals. The cooling temperature was then reduced to 5°C over 16.3 hours, resulting in a temperature of 10°C in the mixture. The cooling temperature of 5°C was maintained for 3 hours. The crystals were then separated by filtration using a Buchner funnel equipped with filter paper and the mother liquor was filtered off by suction. The filter cake was then rinsed with 40.0 g of mother liquor (the temperature of the washing liquid was 11°C). 30.0 g of cooled isobutyl acetate (the temperature of the washing liquid was 10°C) was then added, and the filter cake was re-slurried in the washing liquid by using a spatula and the washing liquid was filtered off by suction. Finally, the crystals were rinsed with 30.0 g of cooled isobutyl acetate. The crystals were then dried in a vacuum oven at 85°C and 20 mbar for 16 hours to give 33.4 g (91.6% yield) of pure product. Gardner Index: 2.9, %T 460nm: 96.0.

[0192] Example 10: Crystallization of Compound MC03 Using Methanesulfonic Acid in an Ester Solvent

[0193] At 65 ℃, 34.0g of compound MC03 (Gardner index is 10.7 and purity is 95.4% crude product) is dissolved in 63.0g ethyl propionate and 0.7g toluene. Cool to a temperature of 46 ℃, then add 0.385g of methanesulfonic acid dissolved in 2.0g ethyl propionate through a funnel and rinse the funnel with 1.0g ethyl propionate subsequently. After this mixture is seeded with 0.18g MC03 crystal, the cooling temperature is reduced to 40 ℃ in 3 hours, then to 20 ℃ in 5 hours, and finally to 0 ℃ in 4 hours, resulting in a temperature of 5 ℃ in the final mixture. 5 ℃ of cooling temperatures are maintained for 0.5 hour. Then separate the crystals and suction filter out the mother liquor by using a Buchner funnel equipped with filter paper. Then rinse the filter cake with 40.0g mother liquor (the temperature of the washing liquid is 9 ℃). 30.0 g of cooled ethyl propionate were then added (temperature of the washing liquid: 9° C.), the filter cake was reslurried in the washing liquid using a spatula and the washing liquid was filtered off with suction. Finally, the crystals were rinsed with 30.0 g of cooled ethyl propionate. The crystals were then dried in a vacuum oven at 85° C. and 20 mbar for 16 hours to give 27.7 g (84.9% yield) of pure product. Gardner index: 2.7, %T460nm: 97.5, purity: 98.0%.

[0194] Example 11: Crystallization of Compound MC03 Using Methanesulfonic Acid in Alcoholic Solvent

[0195] At 60 ℃, 30.0g of compound MC03 (Gardner index is 10.7 and purity is 95.4% crude product) is dissolved in 70.0g 1-methoxy-2-propanol. Cool to a temperature of 36 ℃, then add 0.36g methanesulfonic acid and 0.16g MC03 crystals to put in seed crystals. In 9.7 hours, the cooling temperature is reduced to 7 ℃, resulting in a temperature of 10 ℃ in the final mixture. The cooling temperature of 7 ℃ is maintained for 0.5 hours. Then, the crystals are separated by filtering using a Buchner funnel equipped with filter paper and the mother liquor is filtered out by suction. The filter cake is then rinsed with 30.0g of cooled 1-methoxy-2-propanol (the temperature of the washing liquid is 14 ℃). Then 30.0g of cooled 1-methoxy-2-propanol (the temperature of the washing liquid is 14 ℃) is added, and the filter cake is re-slurried in the washing liquid by using a spatula and the washing liquid is filtered out by suction. Finally, the crystals were rinsed with 30.0 g of cooled 1-methoxy-2-propanol. The crystals were then dried in a vacuum oven at 85° C. and 20 mbar for 16 hours to give 12.0 g (41.5% yield) of pure product. Gardner index: 2.8, %T460nm: 97.4.

[0196] The color properties, transmission at 460 nm and purity of the crystalline merocyanine compounds of the present invention (Examples 1-11) are compared with those of the reference merocyanine crystallized in the absence of acid (Comparative Example) and are listed in Table C:

[0197]

[0198] The crystalline merocyanine compounds in the comparative examples - crystallized in a polar organic solvent in the absence of acid - exhibit significantly higher yellowing properties described by high Gardner indices of 5 or more and low % transmittance values ​​at 460 nm of less than 10. In contrast, the merocyanine compounds in Examples 1-11 - crystallized in the presence of acid according to the present invention - exhibit significantly better color properties expressed by low Gardner indices of 3.2 or less and high % transmittance values ​​at 460 nm of more than 90%.

Claims

1. A method for preparing a crystalline merocyanine compound, comprising the following steps: (a) dissolving the merocyanine compound in a polar organic solvent, (b) crystallizing the merocyanine compound from the solution obtained in step (a), and (c) separating the merocyanine compound from the crystallization mixture of step (b), The method is carried out at a pH of less than 7 according to the following scheme: (i) adding acid A1 in step (a), (ii) adding acid A2 in step (b), or (iii) adding acid A1 in step (a) and acid A2 in step (b), The mesocyanine compound is shown in formula (1): (1) in R1 and R2 are independently hydrogen, C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally interrupted by one or more -O- and / or substituted by one or more OH; R3 is (C=O)OR4 or (C=O)NHR4; R4 is C1-C 22 Alkyl, C2-C 22 Alkenyl, C2-C 22 Alkynyl, C3-C 22 Cycloalkyl or C3-C 22 Cycloalkenyl, wherein the above moiety is optionally substituted with one or more OH and / or interrupted with one or more -O-; and R5 and R6 are independently hydrogen or C1-C 12 alkyl.

2. The method according to claim 1, wherein the merocyanine compound is provided in step (a) at a concentration in the range of 50-600 g / L.

3. The process according to claim 1 or 2, wherein the polar organic solvent is selected from the group consisting of esters, ketones, ethers, alcohols and mixtures thereof.

4. The process according to claim 3, wherein the polar organic solvent is selected from the group consisting of diisopropyl ether, methyl isobutyl ketone, butyl acetate, isobutyl acetate, n-propyl acetate, isoamyl acetate, ethyl 3-ethoxypropionate, ethyl propionate, 1-methoxy-2-propanol, and mixtures thereof.

5. The method according to claim 1 or 2, wherein the crystallization of the merocyanine compound from the crystallization mixture is carried out by: - cooling the crystallization mixture, - adding seed crystals of a merocyanine compound to the crystallization mixture, and / or - Add acid A2.

6. The process according to claim 3, wherein the crystallization of the merocyanine compound from the crystallization mixture is carried out by: - cooling the crystallization mixture, - adding seed crystals of a merocyanine compound to the crystallization mixture, and / or - Add acid A2.

7. The process according to claim 1 or 2, wherein acid A1 and acid A2 are independently selected from organic acids, inorganic acids and mixtures thereof.

8. The process according to claim 3, wherein acid A1 and acid A2 are independently selected from the group consisting of organic acids, inorganic acids and mixtures thereof.

9. The process according to claim 7, wherein acid A1 and acid A2 are independently selected from the group consisting of acetic acid, aspartic acid, benzoic acid, boric acid, bromic acid, hydrochloric acid, citric acid, formic acid, gluconic acid, glutamic acid, lactic acid, malic acid, nitric acid, sulfamic acid, sulfuric acid, methanesulfonic acid, toluenesulfonic acid, tartaric acid, phosphoric acid, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, and mixtures thereof.

10. The process according to claim 1 or 2, wherein acid A1 is formic acid; and wherein acid A2 is methanesulfonic acid.

11. The process according to claim 3, wherein acid A1 is formic acid; and wherein acid A2 is methanesulfonic acid.

12. The process according to claim 5, wherein acid A1 is formic acid; and wherein acid A2 is methanesulfonic acid.

13. The method according to claim 1 or 2, wherein the method is performed according to scheme (ii) or (iii).

14. The method according to claim 3, wherein the method is performed according to scheme (ii) or (iii).

15. The method according to claim 1 or 2, wherein the method is performed according to scheme (i).

16. The process according to claim 15, wherein the polar organic solvent is an ester.

17. The process according to claim 1 or 2, wherein the total amount of acid A1 and / or A2 is in the range from 0.001 to 50% by weight, based on the total weight of the crystallization mixture.

18. The method according to claim 1 or 2, wherein the step (a) of dissolving the merocyanine compound in the polar organic solvent is performed by heating the mixture to a boiling point, and wherein the step (b) of crystallizing the merocyanine compound from the solution obtained in the step (a) is performed by cooling the crystallization mixture to a temperature in the range of -10°C to below the boiling point of the crystallization mixture.

19. The method according to claim 3, wherein the step (a) of dissolving the merocyanine compound in the polar organic solvent is performed by heating the mixture to a boiling point, and wherein the step (b) of crystallizing the merocyanine compound from the solution obtained in the step (a) is performed by cooling the crystallization mixture to a temperature in the range of -10°C to below the boiling point of the crystallization mixture.

20. The method according to claim 5, wherein the step (a) of dissolving the merocyanine compound in the polar organic solvent is performed by heating the mixture to a boiling point, and wherein the step (b) of crystallizing the merocyanine compound from the solution obtained in the step (a) is performed by cooling the crystallization mixture to a temperature in the range of -10°C to below the boiling point of the crystallization mixture.

21. The method according to claim 7, wherein the step (a) of dissolving the merocyanine compound in the polar organic solvent is performed by heating the mixture to a boiling point, and wherein the step (b) of crystallizing the merocyanine compound from the solution obtained in the step (a) is performed by cooling the crystallization mixture to a temperature in the range of -10°C to below the boiling point of the crystallization mixture.

22. The process according to claim 1 or 2, wherein the crystalline merocyanine compound has a Gardner index of less than 5, measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630.

23. The process according to claim 3, wherein the crystalline merocyanine compound has a Gardner index of less than 5, measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630.

24. The process according to claim 5, wherein the crystalline merocyanine compound has a Gardner index of less than 5, measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630.

25. The process according to claim 7, wherein the crystalline merocyanine compound has a Gardner index of less than 5, measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630.

26. The process according to claim 17, wherein the crystalline merocyanine compound has a Gardner index of less than 5, measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630.

27. The process according to claim 18, wherein the crystalline merocyanine compound has a Gardner index of less than 5, measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630.

28. The process according to claim 22, wherein the crystalline merocyanine compound has a Gardner index of less than 3.2, measured on a spectrophotometer PE Lambda 650 according to DIN EN ISO 4630.

Citation Information

Patent Citations

  • Photographic recording element containing a UV absorbent and a silver halide emulsion layer

    US4749643A

  • Merocyanine derivatives

    WO2007071582A1

  • Mixtures comprising benzotriazoles and merocyanines

    WO2009027258A2

  • Mixtures comprising benzotriazoles and merocyanines

    CN101808615A

  • Merocyanine derivatives

    CN103796990A